239 related articles for article (PubMed ID: 23465884)
1. To charge or not to charge: mechanistic insights into neuropathy-associated tRNA synthetase mutations.
Wallen RC; Antonellis A
Curr Opin Genet Dev; 2013 Jun; 23(3):302-9. PubMed ID: 23465884
[TBL] [Abstract][Full Text] [Related]
2. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
[TBL] [Abstract][Full Text] [Related]
3. Cysteinyl-tRNA Synthetase Mutations Cause a Multi-System, Recessive Disease That Includes Microcephaly, Developmental Delay, and Brittle Hair and Nails.
Kuo ME; Theil AF; Kievit A; Malicdan MC; Introne WJ; Christian T; Verheijen FW; Smith DEC; Mendes MI; Hussaarts-Odijk L; van der Meijden E; van Slegtenhorst M; Wilke M; Vermeulen W; Raams A; Groden C; Shimada S; Meyer-Schuman R; Hou YM; Gahl WA; Antonellis A; Salomons GS; Mancini GMS
Am J Hum Genet; 2019 Mar; 104(3):520-529. PubMed ID: 30824121
[TBL] [Abstract][Full Text] [Related]
4. The role of aminoacyl-tRNA synthetases in genetic diseases.
Antonellis A; Green ED
Annu Rev Genomics Hum Genet; 2008; 9():87-107. PubMed ID: 18767960
[TBL] [Abstract][Full Text] [Related]
5. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease.
Meyer-Schuman R; Antonellis A
Hum Mol Genet; 2017 Oct; 26(R2):R114-R127. PubMed ID: 28633377
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitously Expressed Proteins and Restricted Phenotypes: Exploring Cell-Specific Sensitivities to Impaired tRNA Charging.
Kuo ME; Antonellis A
Trends Genet; 2020 Feb; 36(2):105-117. PubMed ID: 31839378
[TBL] [Abstract][Full Text] [Related]
7. The role of tRNA synthetases in neurological and neuromuscular disorders.
Boczonadi V; Jennings MJ; Horvath R
FEBS Lett; 2018 Mar; 592(5):703-717. PubMed ID: 29288497
[TBL] [Abstract][Full Text] [Related]
8. CMT-associated mutations in glycyl- and tyrosyl-tRNA synthetases exhibit similar pattern of toxicity and share common genetic modifiers in Drosophila.
Ermanoska B; Motley WW; Leitão-Gonçalves R; Asselbergh B; Lee LH; De Rijk P; Sleegers K; Ooms T; Godenschwege TA; Timmerman V; Fischbeck KH; Jordanova A
Neurobiol Dis; 2014 Aug; 68():180-9. PubMed ID: 24807208
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy.
McLaughlin HM; Sakaguchi R; Liu C; Igarashi T; Pehlivan D; Chu K; Iyer R; Cruz P; Cherukuri PF; Hansen NF; Mullikin JC; ; Biesecker LG; Wilson TE; Ionasescu V; Nicholson G; Searby C; Talbot K; Vance JM; Züchner S; Szigeti K; Lupski JR; Hou YM; Green ED; Antonellis A
Am J Hum Genet; 2010 Oct; 87(4):560-6. PubMed ID: 20920668
[TBL] [Abstract][Full Text] [Related]
10. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases.
Wei N; Zhang Q; Yang XL
J Biol Chem; 2019 Apr; 294(14):5321-5339. PubMed ID: 30643024
[TBL] [Abstract][Full Text] [Related]
11. Predicting the pathogenicity of aminoacyl-tRNA synthetase mutations.
Oprescu SN; Griffin LB; Beg AA; Antonellis A
Methods; 2017 Jan; 113():139-151. PubMed ID: 27876679
[TBL] [Abstract][Full Text] [Related]
12. A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations.
Meyer-Schuman R; Marte S; Smith TJ; Feely SME; Kennerson M; Nicholson G; Shy ME; Koutmou KS; Antonellis A
Hum Mol Genet; 2023 Jun; 32(13):2177-2191. PubMed ID: 37010095
[TBL] [Abstract][Full Text] [Related]
13. Aminoacyl-tRNA synthetases in Charcot-Marie-Tooth disease: A gain or a loss?
Zhang H; Zhou ZW; Sun L
J Neurochem; 2021 May; 157(3):351-369. PubMed ID: 33236345
[TBL] [Abstract][Full Text] [Related]
14. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
[TBL] [Abstract][Full Text] [Related]
15. Four pedigrees with aminoacyl-tRNA synthetase abnormalities.
Okamoto N; Miya F; Tsunoda T; Kanemura Y; Saitoh S; Kato M; Yanagi K; Kaname T; Kosaki K
Neurol Sci; 2022 Apr; 43(4):2765-2774. PubMed ID: 34585293
[TBL] [Abstract][Full Text] [Related]
16. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities.
Weterman MAJ; Kuo M; Kenter SB; Gordillo S; Karjosukarso DW; Takase R; Bronk M; Oprescu S; van Ruissen F; Witteveen RJW; Bienfait HME; Breuning M; Verhamme C; Hou YM; de Visser M; Antonellis A; Baas F
Hum Mol Genet; 2018 Dec; 27(23):4036-4050. PubMed ID: 30124830
[TBL] [Abstract][Full Text] [Related]
17. Neuropathy-associated histidyl-tRNA synthetase variants attenuate protein synthesis in vitro and disrupt axon outgrowth in developing zebrafish.
Mullen P; Abbott JA; Wellman T; Aktar M; Fjeld C; Demeler B; Ebert AM; Francklyn CS
FEBS J; 2021 Jan; 288(1):142-159. PubMed ID: 32543048
[TBL] [Abstract][Full Text] [Related]
18. Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation.
Storkebaum E
Bioessays; 2016 Sep; 38(9):818-29. PubMed ID: 27352040
[TBL] [Abstract][Full Text] [Related]
19. MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease.
Rips J; Meyer-Schuman R; Breuer O; Tsabari R; Shaag A; Revel-Vilk S; Reif S; Elpeleg O; Antonellis A; Harel T
Eur J Med Genet; 2018 Oct; 61(10):616-620. PubMed ID: 29655802
[TBL] [Abstract][Full Text] [Related]
20. Aminoacyl-tRNA synthetases in medicine and disease.
Yao P; Fox PL
EMBO Mol Med; 2013 Mar; 5(3):332-43. PubMed ID: 23427196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
